Dr Hemang Baxi

Name                                       Dr. Baxi Hemang Ashwinbhai

                                                MD, DM, FACC, FESC

 

Address                                   Office:

Care Institute of Medical Sciences

Nr. Shukan Mall

Off Science City Road, Sola

Ahmedabad-380060, Gujarat, India

Phone: +91-79-27712771(1-5 lines)

Fax:+91-79- 27712770

 

Residence:

A-401, Samay Apartment,

Nr. Azad Society,

Besides Vastrapur Telephone Exchange

Satellite, Ahmedabad 380 015.

Phone: (R) 2674 7703

(M) 98250 30111

 

Email Address             hemang.baxi@cims.me

 

Birth Date                    7th January 1969

 

Former Affiliations as Cardiologist:

  1. N. Mehta Heart Institute, Civil Hospital,

Ahmedabad.

  1. Rajasthan Hospital, Ahmedabad.
  2. Consultant and Interventional Cardiologist,

S.A.L., Ahmedabad.

 

Present Affiliations as Cardiologist:     1.   CIMS Hospital, Ahmedabad

  1.                        Sterling Hospital, Ahmedabad

                                                                       

Education:                               Schooling: St. Xavier High School, Gandhinagar, Gujarat.

Stood 8th in SSC Board, Gujarat.

 

Medical:    B. J. Medical College, Civil Hospital, Ahmedabad

 

Board (Degree)                         Bachelor of Medicine & Surgery (MBBS) 1992

Doctor of Medicine (MD) (Gen. Medicine) 1995

Doctor of Medicine (DM) (Cardiology) 1998 Gold Medalist

                                                Fellow of American College of Cardiology (FACC) – 2015

Fellow of  European College of Cardiology (FESC) – 2015

Fellowship Residency:             – Internship: July 1991-June 1992

Civil Hospital, Ahmedabad.

– Residency in Internal Medicine: July 1992- June 1995

Civil Hospital, Ahmedabad.

– Research Fellow at U N Mehta Cardiology Institute

Civil Hospital, Ahmedabad: July 1995 – Dec 1995

– Residency in Cardiology:  January 1996-April 1998

U N Mehta Heart Hospital, Ahmedabad.

– Research Fellow at U N Mehta Heart Hospital,

Ahmedabad:   April 1998- September 1998

 

Licensure:                                Gujarat Medical Council: G-20576

 

Professional Membership:       Life Member of Cardiac Society of India.

 

Professional Experience:         Interventional Cardiologist

  • Rajasthan Hospital : Oct 1998 to Sept 2001
  • Sterling Hospital : Oct 2001 to Feb 2004
  • A. L Hospital : March 2004 to 2010
  • CIMS Hospital : August 2010 onwards

 

Cardiac Interventions:              Over 10,000 Cardiac Catheterizations including complex

Coronary angiograms, valvular diseases, grafts, etc.

Over 4000 PTCA /Angioplasties including complex

Multivessel grafts, etc.

Over 800 cases in Primary/Rescue Angioplasties

Over 5000 stents used.

Over 500 Balloon Mitral Valvuloplasties

Over 50 Other valvular interventions

 

Peripheral Interventions:          Over 100 cases of Peripheral Interventions

Over 200 cases of Peripheral Diagnostic Angiography

Over 50 Percutaneous Intra vascular Stenting.

Over 50 Pacemaker implantation

 

Research Work and Publications:

 

  • Left main coronary artery disease in Gujarati population. Dr. Sameer Dani, Dr. Anish Chandarana, Dr. Jayesh Rawal, Dr. Bhupesh Shah, Dr. Urmil Shah, Dr. Sharad Jain, Dr. Hemang Baxi, Dr. Hasit Joshi.
  • Pulmonary Stenosis: Long term results of balloon dilatation. Dr. Sameer Dani, Dr. Jayesh Rawal, Dr. Bhupesh Shah, Dr. Sharad Jain, Dr. Urmil Shah, Dr. Hemang Baxi, Dr. Anish Chandarana, Dr. Hasit Joshi.
  • Combination of plain PTCA with stenting in coronary artery disease: immediate and intermediate-term outcome. Dr. S. I. Dani, Dr. B.R. Shah, Dr. U.G. Shah, Dr. H. Baxi, Dr. A. Chandarana, Dr. H. Joshi.
  • Intracoronary Saint Come stents: Short and mid-term follow up results. Dr. B.R. Shah, Dr. S.I. Dani, Dr. U.G. Shah, Dr. S. R. Jain, Dr. A. Chandarana, Dr. H. Baxi.
  • Mehta K.N., Parikh K.H., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik AM, Goyal R.K. Effect of Folate Treatment on Homocysteinemia in Cardiac Patients: A Prospective Study: Indian J Pharmacol. (Abstract)
  • Parikh K.H., Chag M.C, Shah U.G, Baxi H.A., Chandarana A.H., Naik A.M, Goyal R.K., Shah K.J. Acute results and Intermediate term follow up of PCI with Cardioprotection by Balloon Occlusion Distal Protection Device. Indian Heart J. J-233, 2002; 54: 561-568.
  • Mehta K.N., Parikh K.H., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Effect of Folate Treatment on Pharmacological Homocysteinemia in Cardiac Research Patients: A Prospective Study. Pharmacological Research (submitted) 2003.
  • Mehta K.N., Parikh K.H., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Effect of Folate Treatment on Homocysteinemia in Patients: A Prospective Study. Indian J Cardiol.2003; 5: 53
  • Shah K.J., Parikh K.H., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Reversal of Slow-Flow or No-Reflow in PTCA using boluses of IC Adenosine and Sodium Nitroprusside combination. Indian J Cardiol. 2003: 5: 38.
  • Parikh K.H., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M.,Shah K.J., Goyal R.K. Reversal of Slow-Flow or No-Reflow in PTCA using Boluses of IC Adenosine and Sodium Nitroprusside. Suppl to JACC, March 19, 2003; 41 (6), Suppl A: 1101- 201
  • Shah K.J., Parikh K.H., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Prevalence of hyperhomocysteinemia in Western Indian Population with or without Coronary Artery Disease. Indian J Cardiol. (In Press).
  • Parikh K.H., Shah H. D., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Beneficial effects of Distal Protection device in reducing the use of Intracoronary Vasodialators and Glycoprotein IIb/IIIa receptor antagonists during Percutaneous Coronary Interventions. (Accepted for Poster Presentation) Annual conference of Society of Cardiovascular Angiography and Interventions (SCAI) 2004
  • Parikh K.H., Shah H. D., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Improvement in MACE by sequential administration of boluses of Intracoronary Adenosine and Sodium Nitroprusside during Percutaneous Coronary Interventions. (Accepted for Poster Presentation) Annual conference of Society of Cardiovascular Angiography and Interventions (SCAI) 2004
  • Parikh K.H., Shah H. D., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Revascularization in Acute Myocardial Infarction using PercuSurge in Distal Protection. (Accepted for Poster Presentation) Annual conference of Society of Cardiovascular Angiography and Interventions (SCAI) 2004
  • Chag M.C., Shah H. D., Parikh K.H., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Increased Lipoprotein (a) as a strong risk factor for Coronary Artery Disease and the effect of Niacin amongst Indians. European Society of Cardiology (Submitted) 2004.
  • Parikh K.H., Shah H. D., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Beneficial effects of Distal Protection device in reducing the use of Intracoronary Vasodialators and Glycoprotein IIb/IIIa receptor antagonists during Percutaneous Coronary Interventions. European Society of Cardiology (Submitted) 2004.
  • Parikh K.H., Shah H. D., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Improvement in MACE by sequential administration of boluses of Intracoronary Adenosine and Sodium Nitroprusside during Percutaneous Coronary Interventions. European Society of Cardiology (Submitted) 2004.
  • Parikh K.H., Shah H. D., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Revascularization in Acute Myocardial Infarction using PercuSurge in Distal Protection. European Society of Cardiology (Submitted) 2004.
  • Parikh K.H., Shah H. D., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Effect of combination of statins and fenofibrate with acute coronary syndrome undergoing Percutaneous Coronary Interventions. European Society of  Cardiology (Submitted) 2004.

CLINICAL RESEARCH ACCOMPLISHED:

  • Effect of Folate treatment on Homocysteinemia in cardiac patients: A Prospective Study.
  • Pharmacoepidemiology and Risk factors of Hypertension in Gujarat.
  • Reversal of slow or no- reflow During Percutaneous Transluminal Coronary Angioplasty Using Boluses of Intracoronary Adenosine and Sodium Nitroprusside in combination.
  • Acute Results of Intermediate – term follow up of Percutaneous Transluminal Coronary Angioplasty with Cardioprotection by Balloon Occlusion Distal Protection Device.
  • Effect of Tirofiban HCl in Patients with Acute Coronary Syndrome and its comparison with other GPIIb/IIIa antagonists such as Abciximab and Eptifibatide
  • Revascularization Utilizing Balloon Protection in Acute Coronary ischemic Syndrome- An International Registry
  • An International Registry of CYPHER TM-Sirolimus eluting stent
  • High prevalence of Renal Artery Stenosis in Hypertensive patients with Triple vessel Coronary Artery Disease.
  • Effects of Combination of Statins and Fenofibrates with Acute Coronary Syndrome undergoing Percutaneous Coronary Intervention.
  • Effect of Pioglitazone and its combination with Statins in Coronary Artery Disease patients with Hsyperinsulinemia.
  • Comparison of Drug eluting stent with S7 stent.
  • Assessment of Risk factors for Coronary Artery Disease.
  • Effect of Niacin treatment on hyperlipoproteinemia in Coronary Artery Disease patients.
  • Beneficial effects of Distal Protection Device in reducing the use of Intracoronary Vasodialators and Glycoprotein IIb/IIIa receptor antagonists during Percutaneous Coronary Interventions.
  • Comparison of Total Procedural time involved in Primary PCI with or without the use of Distal Balloon Protection system in Thrombotic Coronary lesions. (RAPID trial- Revascularization in Acute myocardial infarction using Percusurge In Distal protection) 

INTERNATIONAL CLINICAL TRIALS: 

1 Co – Investigator for RUBY registry (For India) (2002) To evaluate Percusurge / Guardwire Distal Protection

Device (Presented by Dr. Aman, Switzerland)

Trial completed
2 Co – Investigator at Sterling Hospital for Extract-TIMI 25 Multicentre multi national Trial (2003) Enoxaparin and Thrombolysis Reperfusion for Acute

Myocardial Infarction Treatment Thrombolysis in

Myocardial Infarction –Study 25

Trial completed
3 Co – Investigator for  OASIS-5 Trial (2004) To evaluate the efficacy and safety of fondaparinux

versus Enoxaparin in the acute treatment of  unstable

angina or non ST-segment elevation myocardial

infarction acute coronary syndromes

Trial completed
4 Co – Investigator for  OASIS-6 Trial (2004) To evaluate the efficacy and safety of fondaparinux

Sodium versus control therapy and Glucose-Insulin-

Potassium infusion versus control in broad range in

patients with ST – segment elevation acute myocardial

infarction

Trial completed
5 Co – Investigator for TRUST Trial (2004) To evaluate the safety and efficacy of intravenous

Remodulin in patients( in India) With Pulmonary arterial

hypertension (PAH) in 12-week

Trial completed
6 Co-Investigator for Paediatric Hypertension Trial (2005) Dose ranging study to evaluate the  safety and efficacy

of Olmesartan medoxomil in children and adolescents

with hypertension

Trial completed
7 Co – Investigator for Hypercholesterol study (NK-104-301) at The Heart Care Clinic (2005) Study of Pitavastatin 2 mg vs. Atorvastatin 10 mg and

Pitavastatin 4 mg vs. Atorvastatin 20 mg (Following Up

Titration ) in Patients with Primary Hypercholesterolemia

Or Combined Dyslipidemia

Trial completed
8 Co – Investigator for Neovasc Reducer™ Pilot Study, First in human: (2005) To evaluate the safety of the Neovasc Reducer™ in the treatment of Ischemic heart Disease (IHD), controlled narrowing of

the coronary sinus

Trial completed
9 Co – Investigator For PAPIRUS Trial: Pilot Study, First in Human: Apollo Hospital (2005) Monitoring Pulmonary Artery Pressure by Implantable

Device Responding to Ultrasonic

Signal (REMON Device)

Trial completed
10 Co – Investigator for Export study (2006) Flow improvement in patients with Acute Myocardial

Infarction undergoing either conventional stenting or

a strategy of primary aspiration followed by stenting using the Export Aspiration Catheter: a Prospective, Randomized, Controlled Study

 

Trial completed
11 Co – Investigator for E-five registry (for India) (2006) To Evaluate the ‘Real World’ Clinical Performance of the Medtronic Endeavor™ ABT-578 Eluting Coronary Stent System.

 

Trial completed
12 Co- Investigator for RELY study (2006) Randomized Evaluation of Long term anticoagulant

therapy comparing efficacy and safety of two blinded

doses of dabigatran etexilate with open label warfarin for

the prevention of stroke and systemic embolism in

patients with non-valvular atrial fibrillation : prospective,

multi-centre, Parallel group, non-inferiority trial.

 

Trial completed

 

13 Co – Investigator for Hypercholesterolemia study (NK-104-307) at The Heart Care Clinic (2006) Open label, long-Term (1year) extension study of

Pitavastatin 4 mg QD in patients with Primary

Hypercholesterolemia or combined Dyslipidemia

Trial completed
14 Co – Investigator for  e-SELECT Registry (2007) The e-SELECT Registry : A Multicenter Post Marketing

Survelliance

 Trial completed
15 Co – Investigator for Early ACS trial (2007) Early Glycoprotein Iib/IIIa Inhibition in Non-ST- segment Elevation Acute Coronary Syndrome: A Randomized, Placebo-Controlled Trial Evaluating the Clinical Benefits of Early Front-loaded  Eptifibatide in the Treatment of Patients with Non-ST-segment Elevation Acute Coronary Syndrome (EARLY ACS) Trial completed
16 Co – Investigator  for PLATO trial (2007). A Randomised, Double-blind, Parallel Group, Phase 3,

Efficacy and safety study of AZD6140 Compares with

Clopidogrel for prevention of Vascular Events in

patients with Non-ST or ST Elevation Acute

Coronary Syndromes (ACS) [PLATO – A study of

Platelet inhibition and Patient Outcomes.]

Trial completed
17 Co – Investigator  for OASIS- 7 trial (2007) Randomized, multinational, double-blind study, comparing a high loading dose regimen of Clopidogrel versus standard dose in patients with unstable angina or non-ST segment elevation myocardial infarction managed with an early invasive strategy Trial completed

 

 

18 Co – Investigator  for New Guidewire (2007) First in Man: A Feasibility study to evaluate safety and efficacy of New Guide wire for Crossing Total Occlusions in Coronary Arteries Trial completed

 

19 Co-Investigator for Paediatric Hypertension Trial, The Heart Care Clinic, Ahmedabad (2007) A Randomized, double blind, Placebo-Controlled, Multicentre, Parallel Study Assessing the Efficacy, Safety, and Dose Response of Ramipril for the Treatment of Hypertension in Children and Adolescents Trial completed

 

20 Co-Investigator for Aristotle Trial at The Heart Care Clinic, Ahmedabad (2007) Apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation: Active controlled randomized double blind parallel  arm study to evaluate efficacy and safety of Apixaban in subject with  non valvular Atrial fibrillation Follow-ups ongoing
21 Co-Investigator for Rocket Trial at The Heart Care Clinic, Ahmedabad (2007) Multicenter, Randomized, double-blind – dummy, Parallel-group, Non-inferiority Trial Comparing the Efficacy and Safety of Once-daily oral Rivaroxabab (BAY 59-7939) with Adjusted-dose oral Warfarin for the prevention of Stroke and Non-central-nervous-system systemic embolism in Subjects with Non-valvular Atrial Fibrillation Follow-ups ongoing
22 Co – Investigator  for PROTECT Trial (2007) Patient Related Outcomes with Endeavor versus Cypher stenting Trial: Prospective, multicenter, randomized, two-arm, open-label trial Follow-ups ongoing
23 Co – Investigator  for TMC-CAN-05-02 (2007) A clinical trial comparing Cangrelor to Clopidogrel in subject who require Percutaneous Coronary Intervention Follow-ups ongoing
24 Co – Investigator  for TMC-CAN-05-03 (2008) A clinical Trial comparing treatment with Cangrelor (in combination with usual care) to usual care in subjects who require Percutaneous Coronary Intervention Follow-ups ongoing
25 Co – Investigator  for CL  (Ivabradine) at The Heart Care Clinic (2008) Evaluation of the anti-anginal efficacy Follow-ups ongoing
26 Co – Investigator  for  RE-DEEM at The Heart Care Clinic (2008)

 

Randomized Dabigatran Etexilate dose finding study in patients with acute coronary syndromes post index Event with additional risk factors for cardiovascular complications also receiving aspirin and clopidogrel: Multi-centre, prospective, placebo controlled, group dose escalation trial Trial completed
27 Co-Investigator for Magellan Trial (2008) A Multicenter, Randomized, parallel-group efficacy superiority study in hospitalize medically ill patients comparing rivaroxaban with Enoxaparin Follow-ups ongoing
28 Co-Investigator for Borealis Trial at The Heart Care Clinic Ahmedabad (2008) A multicenter, randomized, double-blind, assessor-blind, non-inferiority study comparing the efficacy and safety of once-weekly subcutaneous biotinylated idraparinux (SSR126517E) with oral adjusted-dose warfarin in the prevention of stroke and systemic thromboembolic events in patient with atrial fibrillation Trial completed
29 Co – Investigator  for Freedom-PAH at The Heart Care Clinic FREEDOM UT –15C Studies (TDE-PH-302 and TDE-PH-304) conducted by United Therapeutics.

 

Ongoing
30 Co – Investigator  for ORBIT – 1 Pilot study to evaluate the safety & performance or the diamond back 360TM orbit Atherectomy system in treating de-NOVO calcified coronary lesions – orbit -1 Trial completed
31 Co-Investigator for AVERROES at The Heart Care Clinic CV 185-048: A Phase 3, Active (Aspirin) Controlled, Randomized, Double-Blind, Parallel arm Study to Evaluate the Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation Trial completed
32 Co – Investigator  for Red-HF at The Heart Care Clinic A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects with Symptomatic Left Ventricular Systolic Dysfunction  and Anemia – 20050222 Amendment 1 Ongoing
33. Co – Investigator  for TAK-442-202 at The Heart Care Clinic A Phase II, double-blind, Randomized, Placebo-controlled study of the safety and Efficacy of TAK-442 in subjects with Acute Coronary Syndrome. Trial completed
34. Co – Investigator  for EISAI-202 at The Heart Care Clinic A Randomized, Double-Blind Placebo controlled study of the safety and tolerability of E5555 and its effect on clinical event and biomarkers in patient with Non ST segment Elevation Acute Coronary Syndrome. Trial completed
35 Co-Investigator for E-Resolute at the Heart Care Clinic Evaluation of the Endeavor Resolute Zolarolumes-Eluting Coronary Stent System in a ‘Real World’ Patient Population. Follow-up ongoing
36 Co – Investigator  of RIVAROXABAN at The Heart Care Clinic Randomized, Double Blind, Placebo Controlled, Event Driven, Multi Center Study To Evaluate The Efficacy And Safety Of Rivaroxaban In Subjects With Recent ACS. Follow-up ongoing
37 Co – Investigator of Pfizer PAH at The Heart Care Clinic B1321001 A Phase 3, Multi Center, Randomized, Double Blind, Placebo Controlled, Safety And Efficacy Study Of Sitaxsentan Sodium In Subjects With Pulmonary Arterial Hypertension. Ongoing
38 Co – Investigator  of Pfizer PAH at The Heart Care Clinic

B1321002

A Phase 3, Multi Center, Open Label Study To Evaluate The Long Term Safety Of Monotherapy Sitaxsentan Sodium And Combination Therapy With Sitaxsentan Sodium And Sildenafil Citrate In Subjects With Pulmonary Arterial Hypertension. Ongoing
39 Co – Investigator of Pfizer PAH at The Heart Care Clinic B1321003 A Phase 3, Multi Center, Randomized, Double Blind, Efficacy And Safety Study Of Monotherapy Sitaxsentan Sodium Versus Combination Therapy With Sitaxsentan Sodium and Sildenafil Citrate In Subjects With Pulmonary Arterial Hypertension Who Have Completed Study B1321001. Ongoing
40 Co – Investigator  of LPL STABILITY at The Heart Care Clinic A Clinical Outcome Study Of Darapladib Versus Placebo In Subjects With Chronic Coronary Heart Disease To Compare The Incidence Of Major Adverse Cardiovascular Event. (MACE) Follow-up ongoing
41 Co – Investigator  of OASIS-8 at The Heart Care Clinic A Prospective Study Evaluating The Safety Of Two Regimens Of Adjustive Intravenous UFH PCI In High Risk Patients With UA/NSTEMI Initially Treated With Subcutaneous Fondaparinux And Referred For Early Coronary Angiography. Follow-up ongoing
42 Co-Investigator of STEM CELL A Randomized, Double Blind, Multi Centric, Placebo Controlled, Single Dose, Phase I/II Study Assessing The Safety And Efficacy Of Intravenous Ex Vivo Cultured Adult Allogenic Mesenchymal Stem Cell In Patients With ST Elevated Acute MI  (STEMI) Patient. Follow-up ongoing
44 Co – Investigator  for RUBY 1Trial at The Heart Care Clinic Ahmedabad (2010) A Randomized, Double Blind, Placebo Controlled, Multi

Center and Parallel Group Study of the Safety,

Tolerability, and Efficacy of YM150 in combination with

Standard  Treatment in Secondary Prevention of

Ischemic Vascular Events in Subjects with Acute

Coronary Syndromes.

Follow-up ongoing
45 Co – Investigator  for AmarinTrial at The Heart Care Clinic Ahmedabad (2010) A phase 3, multi center, placebo controlled, randomized,

double blind, 12 week study with an open label extension

to evaluate the efficacy And safety of AMR101 in patients

with fasting triglyceride levels > 500 mg/dl and

< 2000 mg/dl.

Follow-up ongoing
46 Co Investigator for SASHF RTrial at The Heart Care Clinic Ahmedabad (2008) South Asian Systolic Heart Failure Registry Ongoing
47 Co Investigator for TRAC HF Trial at The Heart Care Clinic Ahmedabad (2009) TRAC HF: Ambulatory Monitoring Using External

Physiological Sensors in Heart Failure Patients.

Ongoing
48 Co-Investigator for Alecardio trial at CIMS hospital Cardiovascular outcomes study  to evaluate the potential of aleglitazar  to reduce reduce  cardiovascular  risk in patients with

recent acute coronary syndrome (ACS) event and

type 2 diabetes mellitus (T2D)

Ongoing
49 Co-Investigator for Timi 52 trial at CIMS hospital A Clinical Outcomes Study of Darapaladib versus

Pleacebo in Subjects Following  Acute Coronary

Syndrome  to Compare the Incidence of Major Adverse

Cardiovascular Events (MACE)

Ongoing
50 Co-Investigator for Resolute Asia trial at CIMS hospital Evaluation of the Endevor Resolute Zotarolimus-Eluting

Coronary Stent System in a Patient Population with

Long Lesion(s) aand/or Dual Vessels in Asia;

Prospective, Multi-center, Non-randomized Study.

Ongoing
51 Co-Investigator for Appraise-2 trial A Phase 3, Randomized, Double-blind, Evaluation of

the safety and Efficacy of Apixaban in subjects with a

Recent Acute Coronary Syndrome

 

Follow-up ongoing

 NATIONAL CLINICAL TRIALS 

1 Co – Investigator  for BIVAFLO Registy (2006) To evaluate the efficacy and safety of BIVAFLO® as an

adjunctive therapy during PCI in moderate-high risk

ACS patients with provisional GP IIb/IIIa inhibitors use.

Trial completed
2 Co – Investigator  for CORREL + C  Trial (2006) The COREL C  Registry : A multicentre Post marketing

Surveillance for clinical and angiographic evaluation of

Corel C stent.

Trial completed
3 Principal Investigator for POLYCAP Trial at VS hospital Ahmedabad(2007) A randomized double blind controlled trial of the efficacy

And safety of POLYCAP Vs its components in subjects

With at least one additional cardiovascular risk factor

Trial completed
4 Co – Investigator for ACUNOVA Trial (2006-2007) A phase III, open label, multicentre, parallel group,

Randomized study to evaluate the safety and efficacy of

Abciximab in Indian patients scheduled for Percutaneous

Coronary Intervention.

Trial completed
5 Co – Investigator for ZYHI Trial at The Heart Care Clinic Ahmedabad (2007) (1) A randomized, double blind parallel group, prospective

dose ranging study of  ZYH 1 with an open fenofibrate arm

to evaluate the efficacy on dyslipidemia in patients without

diabetes  Protocol No. 2001 Ver: 01

(2) A randomized, double blind parallel group, prospective

dose ranging study of ZYH1 with an open pioglitazone arm

to evaluate the efficacy. on dyslipidemia in patients with

diabetes Protocol No. 2003  Ver: 02

(3) A randomized, double blind parallel group, prospective

dose ranging study of  ZYH 1 with an open pioglitazone

arm to evaluate the efficacy on dyslipidemia in patients

with impaired glucose test Protocol No.2004  Ver: 02                           

 

 

Trial completed
Web Design MymensinghPremium WordPress ThemesWeb Development

Successful completion of Chronic Total Occlusion (CTO) Workshop on September 19-20, 2017

September 21, 2017
CIMS Hospital proudly announces the successful completion of Chronic Total Occlusion (CTO) Workshop on September 19-20, 2017 with Dr. Ryohei Yoshikawa - Director of Cardiology Center, Sanda City Hospital, Japan. CIMS Cardiology Team along with Dr. Ryohei Yoshikawa performed 6 cases of CTO- Highly Complex Interventions for chronic 100% blockage.

Mera Hirday Event

September 20, 2017
‘Mera Hriday’ a patient interactive forum between CIMS Family and their patients and well-wishers. The first of its program held on Sunday, September 17, with support of CIMS Foundation (cimscare.com) ,featured Ms. Aishwarya Majmudar where she regaled the audience with a hit series of latest,retro and gujarati folk songs. Live Videos: (www.facebook.com/cimshospitals)

Health Public Lecture On September 17, 2017

September 14, 2017

Newly Expanded CIMS Dentistry with state-of-the-art facilities

August 19, 2017

Launched CIMS Neuroscience and Stroke Unit.

August 19, 2017
A state-of-the-art infrastructure with one of the best and most experienced   TEAMS of Gujarat

First time in India customized 3D printing technology used to treat Aortic Valve Stenosis (narrowing) with TAVI Technology

August 12, 2017
In Landmark achievement in Cardiology by CIMS Hospital ,Ahmedebad, customized 3D printing technology used successfully for the first time in India to treat Aortic Valve Stenosis(narrowing) with TAVI Technology – August 05, 2017.

Know More Press News

CIMS Hospital had its Quality Awards Ceremony on July 10, 2017 to award its star performers of the month

August 5, 2017
CIMS Hospital had its Quality Awards Ceremony on July 10, 2017 to award its star performers of the month. It is ceremony to motivate and encourage all the employees who have somewhere loss interest in performing their duties with extra zeal and enthusiasm. All the winners and other team members participate and enjoy thoroughly, this is a much looked forwarded to event of the month by all.

Heart Transplant on 13/06/2017

August 5, 2017
Heart Transplant done on 13/06/2017, which is a proud moment for CIMS Hospital in announcing the Successful Heart Transplant third time.

Know More Press News

Dr. Dhiren Shah Being Awarded By The Indian Medical Association(IMA) For Medical Excellence In The Field Of Heart Transplant In Gujarat

July 29, 2017

Renal Transplant (CIMS/RIC/2017/08) on 15/06/2017

June 15, 2017
Renal Transplant is done on 15/06/2017, which was approved by Hospital based Ethical committee and Government Authorization committee. Relationship between Donor and Recipient : Mother - Son

Renal Transplant on 22/05/2017

May 23, 2017
Date of Hospital Based Ethical Committee Meeting - 22/05/2017 - 06:00 PM
Sr.No
File No
Status
1
CIMS/RIC/2017/08
Approved
Further stent to "State Authorization Committee"

CIMS Hospital had its Quality Awards Ceremony on May 10, 2017 to award its star performers of the month

May 15, 2017
CIMS Hospital had its Quality Awards Ceremony on May 10, 2017 to award its star performers of the month. It is a monthly ceremony held to motivate and encourage all those who have discharged their duties with extra zeal and enthusiasm. All the winners and other team members participate and enjoy thoroughly … this is a much looked forwarded to event of the month by all.

CIMS Hospital Inaugurates Gujarat’s First Paediatric Bone Marrow Transplant Unit with exclusive focus on Thalassemia.

May 8, 2017
On May 06, 2017, a new Bone Marrow Transplant Unit (BMT) with an exclusive focus towards treating children with thalassemia has been jointly established by CIMS Hospital - Ahmedabad, Sankalp India Foundation - Bangalore, Cure2Chidren - Italy at Ahmedabad. A new hope, a new silver lining has surfaced for little children suffering from the pain and burden of thalassemia.
 

CIMS Hospital created medical history by successfully treating two patients using TAVR (Transcatheter Aortic Valve Replacement)

April 20, 2017
CIMS Hospital treated two patients for aortic stenosis through the new revolutionary technology TAVR (Transcatheter Aortic Valve Replacement) creating medical milestones in the state of Gujarat, under which a new valve is implanted in the heart through the leg (femoral) without surgery.

Renal Transplant (CIMS/RIC/2017/07) on 31/03/2017

March 31, 2017
Renal Transplant is done on 31/03/2017, which was approved by Hospital based Ethical committee and Government Authorization committee. Relationship between Donor and Recipient : Mother - Daughter

CIMS Hospital celebrated International Women’s Day

March 9, 2017
CIMS Hospital celebrated International Women’s Day on 8th March, 2017!   It was fun get together at CIMS Auditorium followed by Cake cutting.

Music of Heart & Lung Course for Physicians and Students – March 05, 2017

March 7, 2017
CIMS Learning Center hosted "Music of Heart & Lung" Certification Course on March 05, 2017. The course imparted knowledge to physicians, interns, MBBS & MD students on different types of heart, sound, murmurs and respiratory sounds. Different sessions were dedicated on basic aspects of various heart, lung, murmurs and respiratory sounds with practical demonstration playing audio clips. The course was a huge success!

Renal Transplant on 04/03/2017

March 4, 2017
Date of Hospital Based Ethical Committee Meeting - 04/03/2017 - 04:00pm
Sr.No
File No
Status
1
CIMS/RIC/2017/07
Approved

CIMS Hospitals Ahmedabad discharges the first Heart Transplant Surgery patient of Gujarat

February 27, 2017
CIMS Hospital Heart Transplant Team gladly announces that the heart transplant patient after two month of post-surgery hospitalisation is stable and has been discharged yesterday. The patient had been under constant monitoring and is fit and able to discharge his daily functions.  

Best Multispecialty Tertiary Care Hospital Of Gujarat

February 21, 2017
CIMS Hospital has recently been awarded the Best Multispecialty Tertiary Care Hospital of Gujarat at the National Quality Excellence Awards, 2017 in Delhi.  Dr. Lubna Mansuri, Associate HOD - Quality Assurance  received this award on behalf of the hospital at the event. 
 
It is very important moment for us and the management would like to thank each member of the CIMS Team for their invaluable contribution for the same. May we continue to achieve such laurels.

Breakthrough In Heart Care – 1st Ever Heart Transplant

February 21, 2017
CIMS Hospital has been recognised and awarded at My FM 94.3 Ahmedabad Entrepreneur and Excellence Awards 2017 for "Breakthrough in Heart care - 1st ever Heart Transplant."
Dr Dhiren Shah and Dr Milan Chag were present to receive this award.
We heartily congratulate the Heart Transplant Team for achieving this success.

100 Most Impactful Global Healthcare Leaders

February 21, 2017
Dr Ashwani Bansal, Chief Operating Officer, has been recognised as 100 MOST IMPACTFUL GLOBAL HEALTHCARE LEADERS at the World Health and Wellness Congress for his outstanding contribution to Healthcare.
We are proud of him and wish him many more such milestones in future. Congratulations.

Best Multispecialty Tertiary Care Hospital Of Gujarat

February 21, 2017
CIMS Hospital has recently been awarded the Best Multispecialty Tertiary Care Hospital of Gujarat at the National Quality Excellence Awards, 2017 in Delhi.  Dr. Lubna Mansuri, Associate HOD - Quality Assurance  received this award on behalf of the hospital at the event. 
 
It is very important moment for us and the management would like to thank each member of the CIMS Team for their invaluable contribution for the same. May we continue to achieve such laurels.

CIMS Hospital is the first hospital in gujarat to have completed a heart transplant

December 20, 2016

With great pleasure, we would like to announce that CIMS Hospital - Care Institute of Medical Sciences in Ahmedabad  is the first hospital in Gujarat to have completed a heart transplant! We salute and congratulate the entire cardiovascular team in this major accomplishment. Now, heart transplants can be done in Gujarat with trust and utmost care!

 

On World Osteoporosis Day (October 20, 2016), CIMS Hospital organized Bone Mineral Density Screening Camp.

October 25, 2016
On World Osteoporosis Day (October 20, 2016), CIMS Hospital organized Bone Mineral Density Screening Camp.
  • More than 120 patients of Gujarat & Rajasthan were examined and BMD test done by Ortho Surgeon.
  • Special Discount Package was given for advanced tests.
It was a team effort under guidance of Dr. Pranav A. Shah, Consultant Orthopaedic & Trauma Surgeon, CIMS Hospital, Ahmedabad.

CIMS Hospital has achieved Joint Commission International (USA) accreditation and earned Gold Seal of Approval in Quality and Patient Safety

October 12, 2016

CIMS Learning Centre hosted “Sleep Disordered Breathing “ Course – August 21, 2016

August 23, 2016
CIMS Learning Centre hosted “Sleep Disordered Breathing"  certification course on August 21, 2016All doctors in attendance thoroughly enjoyed the session !

CIMS Neonatal & Pediatric Critical Care and Dental department’s participation at Kidzania on August 21, 2016 at Convention Hall, GMDC, Ahmedabad was a resounding success !

August 23, 2016
CIMS Neonatal & Pediatric Critical Care and CIMS Dentistry department organized Pediatric and Dentistry camp in association with Kidzania on August 21, 2016 at Convention Hall, GMDC, Ahmedabad. The screening of 110 kids was done in a camp by our team of Dr. Snehal Patel and Dr. Chandni Patel.  

Organ Donation Week at CIMS (18 – 23 Aug 2016)

August 11, 2016
CIMS Hospital is organizing   "Organ Donation Week"  from 8th August , 2016 to 13th August, 2016. Join us for a noble cause.

"Souls Go to Heaven. Organs Don't."

Renal Transplant on 03/08/2016

August 4, 2016
Renal Transplant is done on 03/08/2016, which was approved by Hospital based Ethical committee and Government Authorization committee.
Relationship between Donor and Recipient : Mother in law - Son in law

On World Hepatitis Day, join us for general public lecture on “Viral Hepatitis/Liver Disease” at CIMS Auditorium, CIMS Hosp., Ahmedabad at 12 PM

July 26, 2016
World Hepatitis Day - 28 July, 2016
On World Hepatitis Day, join us for general public lecture on "Viral Hepatitis/Liver Disease" at CIMS Auditorium, CIMS Hosp., Ahmedabad  at 12 PM.  

Date of Hospital Based Authorization Committee Meeting – 15/07/2016

July 15, 2016
Date of Hospital Based Authorization Committee Meeting - 15/07/2016 - 12:30pm
Sr.No
File No
Organ
Status
1
CIMS/RIC/2016/05
Kidney
Approved

On the occasion of 2nd International Yoga Day, CIMS organized “Yoga Session” on 21st June,2016 !

June 24, 2016
On the occasion of 2nd International Yoga Day, CIMS organized "Yoga Session" on 21st June,2016 ! IMG_1531 IMG_1526

We are getting Bigger and Better ! CIMS has newly launched the new 10-storey “CIMS East Block” and CIMS Khambatta Linac Centre with state-of-the-art facilities and latest technology

June 24, 2016
We are getting Bigger and Better ! CIMS has newly launched the new 10-storey "CIMS East Block" and CIMS Khambatta Linac Centre with state-of-the-art facilities and latest technology

We congratulate Dr Keyur Parikh, Chairman, CIMS Hospital for graduating as an MBA at the Harvard Business School, Owner/President Management (OPM Program-48)

April 12, 2016

Management of Drug Resistant Tuberculosis

April 6, 2016
Course Directors : Dr.Surbhi Madan / Dr.Bhavini Shah
Guest Faculty: Dr. Neha Gupta
Date: April 10, 2016 (Sunday)
Duration : 1 Day
Number of seats : 50
Venue 
: CIMS Auditorium
Program Overview:
This course is designed for physicians who are involved in the management of patients with tuberculosis. Due to emergence of drug resistant tuberculosis, the approach towards treatment has changed and is continuously evolving. It is important to have updated knowledge about the new diagnostic strategies and treatment approaches for optimal management. The aim of this course is to discuss the same with the help of clinical cases.
Program Highlights:
  • Newer diagnostics: Emphasis on molecular tests
  • Importance of culture and DST (Drug susceptibility testing)
  • Define various categories of drug resistant TB
  • Treatment of drug resistant TB- Program based or individualized?
  • Important adverse effects of second line drugs
  • Immune reconstitution in tuber culosis: Clinical relevance
  • Role of surgery in treatment
  • Newer drugs
  • Interactions amongst antituberculous drugs
Registration Fees: 1,000/- (Up to one month before course date)
Registration Fees: 1,500/-(Within 15 days before course date)
Spot Registration Fees: 2,000/-
Certificate of attendance will be given at the end of the Internship

Renal Transplant on 21/03/2016

March 26, 2016
Renal Transplant is done on 21/03/2016, which was approved by Hospital based Ethics Committee. Relationship between Donor and Recipient - Wife-Husband

Renal Transplant is done on 10/02/2016

February 25, 2016
Renal Transplant is done on 10/02/2016, which was approved by Hospital based Ethics Committee. Relationship between Donor and Recipient - Mother-Son

We announce opening of comprehensive cancer surgery department with Radiation and medical oncology unit at CIMS. Our motto at ‘CIMS Cancer Centre’ is – prevention, detection, treatment and rehabilitation with personalized care.

February 4, 2016

ALL INDIA CRITICAL CARE HOSPITAL RAN KING SURVEY 2016 We are proud to announce that we are elected No. 1 hospital in Gastroenterology and Hepatology & Gynaecology and Obstetrics among all multispecialty hospitals in Ahmedabad

January 29, 2016
All India Critical Care Ranking Survery

Renal Transplant is done on 01/12/2015

December 5, 2015
Renal Transplant is done on 01/12/2015, which was approved by Hospital based Ethics Committee.
Relationship between Donor and Recipient - Mother-Son

WEIGHT LOSS WEEK at CIMS Hospital, November 1 – 7, 2015

October 29, 2015
Obestiy Week Leaflet

CIMS First Renal Transplant is planned on 17/08/2015,which is approved by Hospital based Ethics Committee.Relationship between Donor and Recipient – Father-Son

August 14, 2015

Happy Independence Day

August 12, 2015
Independence Day Email

CIMS Joint Replacement Department Offers Specialized Knee & Hip Replacement Package at Rs. 1.25 Lac only

August 6, 2015
CIMS Jonit Replacement Detapartment Freedom Month

CIMS Hospital Welcomes Dr. Vipul Kapoor and Dr. Tejas V. Patel

June 5, 2015
CIMS Hospital Welcomes Dr. Vipul Kapoor,  Interventional Cardiologist, MBBS, MD (Gen. Medicine), DNB (Cardiology), MNAMS, FESC and Dr. Tejas V. Patel, Interventional Cardiologist, MBBS, MD (Gen. Medicine), DM (Cardiology) CMC – Vellore joining with CIMS Cardiac Team. Dr Tejas &  Dr Vipul

CIMS Hospital has been awarded Best Multi-Speciality Hospital in Ahmedabad

June 4, 2015
We proudly announce that CIMS Hospital has been awarded Best Multi-Speciality Hospital in Ahmedabad at Brand Achievers Awards 2015. Brand Achievers Awards

First in Versa-HD in India

May 22, 2015
First in Versa-HD in India
A recent milestone achieved by CIMS Cancer Center in Radiotherapy is the AERB approval to use FFF (Flattening Filter- Free) for clinical use. By removing the flattening filter from the linear accelerator, greater dose rate can be achieved due to the physiologic property of flat beam. Advanced treatment like SRS (Stereotactic Radio Surgery) SRT (Stereotactic Radio Therapy) and SBRT (Stereotactic Body Radiation Therapy for Lungs and Prostate) with use of state of art planning system can now be used to modulate non-flat, high dose rate beams to achieve highly conformal dose distributions with a reduced treatment time.

Happy Mother’s Day

May 9, 2015
Happy Mothers Day

First time in India Heart Valve replacement on Beating heart — Technological Breakthrough.

April 10, 2015
First time in India Heart Valve replacement on Beating heart — Technological Breakthrough.

At CIMS hospital Ahmedabad a breakthrough technological surgery was performed for the first time in India on an 82 year old gentleman who had stenosis of one of the valve with heart failure, bad lungs , multiple blocks in the peripheral arteries and mild kidney disease . He had a past history of 2 times hospitalisation for heart failure symptoms in last 3 months . This heart failure was because of stenosed Heart Valve.

Only solution or treatment for this patient was to replace the valve. For valve replacement a patient has to undergo open heart surgery, wherein the heart is stopped, opened, the valve is replaced and then the heart is restarted. During this operative time, the patient is supported on Heart Lung machine.

Because of his age, poor heart function , bad lungs , and multiple blocks in arteries, it was very high risk case for open heart surgery. For such cases, a technological advanced treatment TAVI ( Trans catheter Aortic Valve Implantation) is now possible. This hybrid procedure , wherein Valve Replacement is done on beating heart ( without stopping the heart) utilised the combined skills of a heart surgeon and a Cardiologist . Procedure is done in the same way an Angioplasty is done. This procedure was successfully executed by the team of doctors of CIMS hospital: Dr Dhiren Shah (Cardiac Surgeon) Dr Milan Chag (Cardiologist), Dr Chintan Seth , Dr Hiren Dholakia ( Cardiac Anasthetist).

In today’s technology driven-era and with good infrastructure hospitals, high risk patient and geriatric patients can get treatment and can get new lease of life.

India-Heart-Valve-replacement

Rare case of cardiac surgery in pregnancy with twins

April 3, 2015
A young female, first pregnancy with twins was a great joy for the family. However, it turned into a nightmare when sudden onset fever and breathlessness led to diagnosis of hole in heart (VSD) and main artery (aorta) blood leaking in RT chamber of heart (RSOV).
Semiurgent, highrisk surgery was planned during 5th month after counselling from cardiologist.
Multidisciplinary team of cardiac surgeon (paediatric), cardiac anaesthesiologist, gyenecologist, perfusionist and nursing staff made this operation successful.
Vigilant advance monitoring of mother and baby, haemodynamic monitoring in mother, surgical expertise and expert postop care is the key to this success.
Mother & baby both are well.
RARE-CASE-OF-CARDIAC-SURGERY-IN-PREGNANCY-WITH-TWINS

CIMS Cardiac team is organising endovascular workshop for patients.

March 27, 2015
CIMS Cardiac team is organising endovascular workshop for patients with blockage in Neck (carotid ), Legs, Abdomen, Arm vessels and for Patients with problems related to veins.

RENAL TRANSPLANT now at CIMS Hospital with the backing of world class technology

March 27, 2015
RENAL TRANSPLANT now at CIMS Hospital with the backing of world class technology

CIMS Hospital conducted Global Nursing Skill Demonstration (GNSD) Training program

March 21, 2015
CIMS Hospital conducted Global Nursing Skill Demonstration (GNSD) Training program for the NURSES by Mecca Group of Industries (A Corporate Social Responsibility Initiative program). The session plans are based on the guidelines of American Nursing Association and relevant International Nursing Study Papers and Course Modules. GNSD program aim's to provide exposure to global nursing practices and soft skills by Skill demonstration tutorials, lectures & demonstrations through sharing news & views, latest developments and discoveries. GNSD program covers various aspects of global nursing skills, practices and procedures helpful in enriching profile of the Nurses.

CIMS Women announces a special discounted checkup camp for WOMEN

March 4, 2015
On the eve of International Women's Day CIMS Women announces a special discounted checkup camp for WOMEN on March 7, 2015, Saturday.

CIMS Hospital organised basic health check-up camp at State Bank of India

February 23, 2015
CIMS Hospital organised basic health check-up camp at State Bank of India,Administrative office, Ambawadi, Ahmedabad on 19-02-2015, Thursday

CIMS HOSPITAL announce the opening of CIMS LIONS CARDIAC CENTER

February 23, 2015
CIMS HOSPITAL announce the opening of CIMS LIONS CARDIAC CENTER at Lions General Hospital, Mehsana.

CIMS Hospital organised basic health check-up camp at TATA Motors

February 23, 2015
CIMS Hospital organised basic health check-up camp at TATA Motors, Sanand,Ahmedabad on 12-02-2015, Thursday

CIMS Hospital Joint Replacement Team organized a seminar “Know Before You Go Knee Replacement Surgery”

February 13, 2015
CIMS Hospital Joint Replacement Team organized a seminar "Know Before You Go Knee Replacement Surgery"

Uttrayan Safety Week- PR

January 19, 2015
Uttrayan Safety Week- PR

CIMS CRICKET TEAM has won DECATHLON Corporate Premier League….

December 27, 2014
CIMS CRICKET TEAM has won DECATHLON Corporate Premier League played at DECATHLON ground on December 21, 2014. This was played among 32 Corporate teams like Wagh Bakri, ADC, DOCOMO, Godrej, Airtel, Torrent, Vodafone etc.

CIMS has traditionally celebrated a wonderful Christmas….

December 27, 2014
CIMS has traditionally celebrated a wonderful Christmas with all patients and staff - Christmas Bells, Christmas Trees, Sending Greeting Cards , Sharing Christmas Cakes , Giving Gifts and of course Santa Claus who gave lots of wishes to our patients and staff. We also arranged a Mehendi competition for our staff which turned out to be a very enjoyable activity for all.

CIMS Hospital wins at The Times of India Healthcare Achievers Awards 2014

December 23, 2014
CIMS Hospital wins at The Times of India Healthcare Achievers Awards 2014 at Delhi the only hospital in India to win 2 awards :
  1. Trendsetter award in customer service excellence (Across India)
  2. Best Multispeciality Hospital in Ahmedabad
Times of India Page-12
Times of India Page-13

CIMS Hospital has been awarded The MOST TRUSTED….

December 12, 2014
CIMS Hospital has been awarded The MOST TRUSTED MULTI-SUPER SPECIALITY HOSPITAL BRAND OF THE YEAR by All India Economy Survey Award Council, (a ‘Quasi-Government' body under the auspices of Ministry of Commerce and Industry, Govt of India).

Brand of the year

health check-up camp at Indian Railways Catering and Tourism Corporation Ltd (IRCTC)

December 1, 2014
CIMS Hospital successfully conducted a basic health check-up camp at Indian Railways Catering and Tourism Corporation Ltd (IRCTC) Ahmedabad on 24th & 25th Nov,2014. Total 120 employees had been screened during camp with RBS, ECG, Blood Pressure and Doctor Consultation.

IRCTC Camp

A Health Talk was given on Life style Modification by Dr. Urmil Shah

December 1, 2014
A Health Talk was given on Life style Modification by Dr. Urmil Shah(Cardiologist) to the Admin Executive Officers of Tata Nano. Total 60 Executive officers was participated in Talk.

Tata Nano Camp

World Heart Day

September 23, 2014
On the eve of "World Heart Day" CIMS Hospital organizes CIMS Heart Walk on September 28, 2014 (Sunday) from 7.00 am to 9.00 am at Parimal Laughing Club, Parimal Garden, Ahmedabad.

World Heart Day Leaflet

Congratulations to Dr Milan Chag for acceptance of paper at TCT 2014 at Washington DC, USA

September 15, 2014
Congratulations to Dr Milan Chag for acceptance of paper at TCT 2014 at Washington DC, USA, at the largest Angioplasty conference of the world.

CIMS Hospital has been awarded a THREE STAR rating

September 6, 2014
CIMS hospital has been awarded a THREE STAR rating by the Bureau Of Energy Efficiency at a ceremony held in New Delhi by the Honorable Minister of State for Petroleum & Natural Gas - Mr Dharmendra Pradhan on 02 Sep 2014.This award brings us a step closer to our aim of achieving the green building certification and conservation of energy through judicious usage and strict discipline.

Three Start Rating Award

Hip & Knee Replacement Surgery Camp

August 27, 2014
CIMS Hospital announces Hip & Knee Replacement Surgery Camp

Joint Replacement (English) Ad

Advanced ECG Learning Course….

August 22, 2014
Indian Society of Electrocardiology (ISE) & Ahmadabad Physician Association (APA) Organizes Advanced ECG Learning Course on August 31,2014, Sunday at Radisson Blu, Ahmadabad.

ECG Learning Course Brochure

Endovascular Workshop…

August 16, 2014
CIMS Hospital organized Endovascular Peripheral Workshop by Dr. Ashit Jain (USA) on August 21-22, 2014 (9.00 am to 3.00 pm) Endovascular Workshop Brochure

CIMS Hospital & Spectrum Medical Foundation bring “Paediatric Advanced Life Support (PALS) AHA certified course” & “Pediatric Critical Care Workshop” on August 23-24, 2014.

August 2, 2014
CIMS Hospital & Spectrum Medical Foundation bring “Paediatric Advanced Life Support (PALS) AHA certified course” & “Pediatric Critical Care Workshop” on August 23-24, 2014.

PALS Workshop Brochure & Registration Form

CIMS Hospital Cardiothoracic Vascular Surgery Department & Gujarat Cardiothoracic Surgeons Club organized first of its kind in Gujarat a Live Workshop on Hypertrophic obstructive cardiomyopathy (HOCM) – Extended Septal Myectomy on Sunday, the 27th of July 2014

August 1, 2014
CIMS Hospital Cardiothoracic Vascular Surgery Department & Gujarat Cardiothoracic Surgeons Club organized first of its kind in Gujarat a Live Workshop on Hypertrophic obstructive cardiomyopathy (HOCM) – Extended Septal Myectomy on Sunday, the 27th of July 2014

View More

“CIMS Hospital,Clinic By Medical Expert Team of CIMS at Dares Salam &Mwanza,Tanzania,East Africa”

July 24, 2014

American College of Cardiology …

July 7, 2014
American College of Cardiology - ACC (Leading Institute of the World) certifies CIMS Hospital as an ACC - Center of Excellence. Amongst the first in World and India and only in Gujarat for high-standards of medical practice and dedication in providing quality cardiovascular care.

CIMS Hospital has launched Certified GNP (Good Nebulization Practice) …

June 7, 2014
CIMS Hospital has launched Certified GNP (Good Nebulization Practice) campaign for the nursing staff of the hospital to practice improved nebulization therapy (the practice of administering medication through a machine in the form of a mist into the lungs ) to reduce chances of infection. CIMS Hospital, Ahmedabad, is the first hospital in Gujarat to train about 250 nurses and certify them for the same.

Dr. Keyur Parikh attended (Owner/President Management Program 48) …

June 5, 2014
Dr. Keyur Parikh attended (Owner/President Management Program 48) OPM 48 Program at Harvard Business School - Boston USA from May 11th - May 30th 2014

Dr. Ateet Sharma attended master hip replacement course at Seoul,…

June 2, 2014
Dr. Ateet Sharma attended master hip replacement course at Seoul, South Korea in April 2014.

Dr. Amir Sanghvi visited American academy of orthopaedic …

June 2, 2014
Dr. Amir Sanghvi visited American academy of orthopedic surgeons at New Orleans USA in march 2014.

Dr. Chirag Patel & Dr. Hemang Ambani attended Indianapolis USA for revision knee replacement and attune knee course …

June 2, 2014
Dr. Chirag Patel and Dr. Hemang Ambani attended Indianapolis USA for revision knee replacement and attune knee course in May-2014.

CIMS Hospital celebrated its Annual Day on March 3, 2014….

April 5, 2014

Annual Day Celebration

CIMS Hospital celebrated its Annual Day on March 3, 2014. It is a day looked forward to by the entire CIMS family as it gives all an occasion to celebrate and interact with each other. The Annual Day was an evening full of fun and frolic with amazing and entertaining performances by the staff and the doctors whose hidden talents came to the fore. Sports and games were also organised as a part of the Annual Day celebrations. Here we take a short recall on all our memories via picture tour.

CIMS Hospital Pvt. Ltd. has been awarded …

January 6, 2014
We announce with immense pride that CIMS Hospital Pvt. Ltd. has been awarded the "Healthcare Excellence Award for Best Innovative Hospital in Gujarat" for the year 2013.
 
This award stands tall as an achievement for the collective efforts of everyone in the CIMS family reflecting upon an organizational culture that has always been embraced innovation and technological initiatives since its inception. We at CIMS thank all of you for being with us in the journey throughout!

Dr. Keyur Parikh has been awarded the AAPI Global Leadership award….

January 6, 2014
We announce with immense pride that our Chairman - Dr. Keyur Parikh has been awarded the AAPI Global Leadership award at the hands of Honorable Chief Minister - Mr. Narendra Modi. We Congratulate Dr. Keyur Parikh for the great achievement ! Read More